Uricases: reflections on recent developments in the management of challenging gout patients
Oral urate-lowering therapy (ULT) is key to treating gout. However, many patients receiving oral ULT do not achieve the target serum urate (SU) levels, partly because some patients cannot tolerate or have contraindications to their use, mainly due to comorbidities. This may lead to uncontrolled gout...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Open Exploration Publishing Inc.
2024-10-01
|
| Серии: | Exploration of Musculoskeletal Diseases |
| Предметы: | |
| Online-ссылка: | https://www.explorationpub.com/uploads/Article/A100770/100770.pdf |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|